Tetanus and Diphtheria Toxoids Adsorbed

BIOLOGICAL3 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Mayo Clinic

Conditions

Advanced Fallopian Tube CarcinomaAdvanced Fallopian Tube High Grade Serous AdenocarcinomaAdvanced Ovarian CarcinomaAdvanced Ovarian CarcinosarcomaAdvanced Ovarian Clear Cell AdenocarcinomaAdvanced Ovarian Endometrioid AdenocarcinomaAdvanced Ovarian High Grade Serous AdenocarcinomaAdvanced Primary Peritoneal Carcinoma

Phase 1

Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune Systems

CompletedNCT00006066

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections

End: 2006-06-30Target: 92Updated: 2021-11-01

Phase 2

Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants

CompletedNCT03589768

National Institute of Allergy and Infectious Diseases (NIAID)Clostridium Difficile Immunisation, Diphtheria, Diphtheria Immunisation +3

Start: 2019-01-24End: 2020-07-01Updated: 2025-05-21

Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial

RecruitingNCT06639074

Mayo ClinicAdvanced Fallopian Tube Carcinoma, Advanced Fallopian Tube High Grade Serous Adenocarcinoma, Advanced Ovarian Carcinoma +15

Start: 2024-11-08End: 2027-12-31Target: 78Updated: 2025-10-02

Related Papers

Safety and immunogenicity of a single dose of Tdap compared to Td in pregnant women in Mali and 3 its effect on infant immune responses: a single-centre, randomised, double-blind, active-controlled phase 2 study.

2024-03-289 citations